Related Experiment Video
Updated: Feb 22, 2026

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
Percutaneous Coronary Intervention Versus Surgery in Left Main Stenosis-A Meta-Analysis and Systematic Review of
Safi U Khan1, Hammad Rahman1, Adeel Arshad2
1Guthrie Health System/Robert Packer Hospital, Sayre, PA, USA.
Insights
Percutaneous coronary intervention (PCI) is safer for left main coronary artery disease initially, but coronary artery bypass graft (CABG) surgery shows better long-term results. Both treatments have comparable outcomes at one year.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Cardiac Surgery
Background:
- Left main coronary artery (LMCA) disease poses significant risks.
- Treatment decisions involve balancing procedural safety with long-term efficacy.
- Percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) are primary treatment options.
Purpose of the Study:
- To compare the safety and efficacy of PCI versus CABG for LMCA disease.
- To evaluate short-term and long-term clinical outcomes.
- To assess periprocedural adverse events associated with each modality.
Main Methods:
- Systematic review and meta-analysis of six randomized controlled trials (RCTs).
- Searched major databases: PubMed/Medline, Embase, and Cochrane Library.
- Pooled estimates using random effects model; reported binary outcomes as risk ratios (RR) and continuous outcomes as mean differences (MD) with 95% confidence intervals (CI).
Main Results:
- 3794 patients were randomized; mean age 64.7 years, 74.4% male, mean Logistic EURO score (LES) 2.9.
- PCI showed reduced major adverse cardiovascular events (MACE) at 30 days (RR: 0.55; 95% CI, 0.41-0.75) but similar MACE at 1 year (RR: 1.15; 95% CI, 0.92-1.45).
- CABG demonstrated superior 5-year MACE rates (RR: 1.32; 95% CI, 1.13-1.53), driven by higher target vessel revascularization (TVR) and myocardial infarction (MI) with PCI. PCI was safer periprocedurally, with lower rates of MI, stroke, bleeding, and transfusion needs.
Conclusions:
- PCI offers reduced MACE at 30 days and comparable MACE at 1 year compared to CABG for LMCA disease.
- CABG is more effective for mid- to long-term outcomes, particularly in reducing TVR and MI.
- PCI is a safer procedure concerning periprocedural adverse events, including MI, stroke, and bleeding.
Objective:
To investigate the safety and efficacy of percutaneous coronary interventions (PCI) versus coronary artery bypass graft (CABG) surgery for left main coronary artery (LMCA) disease.
Methods:
Six randomised controlled trials (RCTs) were reviewed by searching PubMed/Medline, Embase and the Cochrane Library. Estimates were pooled according to random effects model. Binary outcomes were reported as risk ratio (RR) and continuous outcomes were reported as mean difference (MD) with 95% confidence interval (CI).
Results:
3794 patients were randomised into PCI and CABG arms. Mean age of the total population was 64.7 years, 74.4% were male and mean Logistic EURO score (LES) was 2.9. When compared with CABG, patients treated with PCI had reduced risk of major adverse cardiovascular events (MACE) at 30 days: (RR: 0.55; 95% CI, 0.41-0.75; p<0.001; I2=0) but similar risk at 1year (RR: 1.15; 95% CI, 0.92-1.45; p=0.22; I2=0). Five years MACE rates favoured CABG (RR: 1.32; 95% CI, 1.13-1.53; p<0.001; I2=0) driven by a higher rate of target vessel revascularisation (TVR) (RR: 1.71; 95%CI, 1.38-2.12; p<0.001; I2=0) and myocardial infarction (MI) (RR: 1.97; 95%CI, 1.28-3.04; p<0.001; I2=22). Percutaneous coronary intervention was comparatively a safer procedure with lower rates of periprocedural adverse events including MI, stroke, bleeding events and need for blood transfusions.
Conclusion:
Percutaneous coronary intervention reduced MACE at 30days with comparable MACE at 1year. However, CABG was a more effective modality when considering mid- to long-term outcomes. PCI is a safer procedure with regards to periprocedural adverse events.
More Related Videos
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
08:12Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Related Concept Videos
Mitral Stenosis III: Medical Management
Peripheral Artery Disease III: Interprofessional Care
Cardiac Catheterization III: Left Heart Catheterization
Coronary Artery Disease V: Interprofessional Care